Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31false7No description of principal activity2023-04-01false7falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 07566782 2023-04-01 2024-03-31 07566782 2022-04-01 2023-03-31 07566782 2024-03-31 07566782 2023-03-31 07566782 c:Director1 2023-04-01 2024-03-31 07566782 d:PlantMachinery 2023-04-01 2024-03-31 07566782 d:PlantMachinery 2024-03-31 07566782 d:PlantMachinery 2023-03-31 07566782 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 07566782 d:MotorVehicles 2023-04-01 2024-03-31 07566782 d:MotorVehicles 2024-03-31 07566782 d:MotorVehicles 2023-03-31 07566782 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 07566782 d:OfficeEquipment 2023-04-01 2024-03-31 07566782 d:OfficeEquipment 2024-03-31 07566782 d:OfficeEquipment 2023-03-31 07566782 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 07566782 d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 07566782 d:Goodwill 2024-03-31 07566782 d:Goodwill 2023-03-31 07566782 d:CurrentFinancialInstruments 2024-03-31 07566782 d:CurrentFinancialInstruments 2023-03-31 07566782 d:Non-currentFinancialInstruments 2024-03-31 07566782 d:Non-currentFinancialInstruments 2023-03-31 07566782 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 07566782 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 07566782 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 07566782 d:Non-currentFinancialInstruments d:AfterOneYear 2023-03-31 07566782 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2024-03-31 07566782 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2023-03-31 07566782 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-03-31 07566782 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-03-31 07566782 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2024-03-31 07566782 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2023-03-31 07566782 d:ShareCapital 2024-03-31 07566782 d:ShareCapital 2023-03-31 07566782 d:RetainedEarningsAccumulatedLosses 2024-03-31 07566782 d:RetainedEarningsAccumulatedLosses 2023-03-31 07566782 c:FRS102 2023-04-01 2024-03-31 07566782 c:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 07566782 c:FullAccounts 2023-04-01 2024-03-31 07566782 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07566782 d:HirePurchaseContracts d:WithinOneYear 2024-03-31 07566782 d:HirePurchaseContracts d:WithinOneYear 2023-03-31 07566782 d:HirePurchaseContracts d:BetweenOneFiveYears 2024-03-31 07566782 d:HirePurchaseContracts d:BetweenOneFiveYears 2023-03-31 07566782 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: 07566782










KEITH HARTE BLOODSTOCK LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
  
REPORT TO THE DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF KEITH HARTE BLOODSTOCK LIMITED
FOR THE YEAR ENDED 31 MARCH 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Keith Harte Bloodstock Limited for the year ended 31 March 2024 which comprise  the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountantswe are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal .com/uk/en/about-us /regulation/ethics /acca-rulebook.html.

This report is made solely to the Board of directors of Keith Harte Bloodstock Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Keith Harte Bloodstock Limited and state those matters that we have agreed to state to the Board of directors of Keith Harte Bloodstock Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal .com/content/dam/ACCA_Global /Technical /fact/technical-factsheet -163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Keith Harte Bloodstock Limited and its Board of directors, as a body, for our work or for this report. 

It is your duty to ensure that Keith Harte Bloodstock Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Keith Harte Bloodstock Limited. You consider that Keith Harte Bloodstock Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Keith Harte Bloodstock Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



Alder Demain & Akers Ltd
 
Accountants
  
2 Michaels Court
Hanney Road
Southmoor
Oxford
OX13 5HR
8 August 2024
Page 1

 
KEITH HARTE BLOODSTOCK LIMITED
REGISTERED NUMBER: 07566782

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
39,984
53,314

  
39,984
53,314

Current assets
  

Stocks
 6 
42,084
67,760

Debtors: amounts falling due within one year
 7 
47,275
25,950

Cash at bank and in hand
 8 
33,083
39,053

  
122,442
132,763

Creditors: amounts falling due within one year
 9 
(103,643)
(122,033)

Net current assets
  
 
 
18,799
 
 
10,730

Total assets less current liabilities
  
58,783
64,044

Creditors: amounts falling due after more than one year
 10 
(32,392)
(45,035)

  

Net assets
  
26,391
19,009

Page 2

 
KEITH HARTE BLOODSTOCK LIMITED
REGISTERED NUMBER: 07566782
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Capital and reserves
  

Called up share capital 
  
2
2

Profit and loss account
  
26,389
19,007

  
26,391
19,009


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 8 August 2024.




................................................
Keith Harte
Director

The notes on pages 4 to 14 form part of these financial statements.

Page 3

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

Keith Harte Bloodstock Limited is a company limited by shares which was incorporated in England.
The principal place of business is:
Mill Farm
Mill Lane
Finchingfield
Essex CM7 4PQ
The company's principal activity is that of a livery services.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Page 4

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 5

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.8

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 6

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)


2.9
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Plant & machinery
-
25%
Motor vehicles
-
25%
Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.10

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.11

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.12

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.13

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.14

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 7

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

3.


Employees

2024
2023
£
£

Wages and salaries
74,628
67,582

Cost of defined contribution scheme
477
555

75,105
68,137


The average monthly number of employees, including directors, during the year was 7 (2023 - 7).


4.


Intangible assets




Goodwill

£



Cost


At 1 April 2023
20,250



At 31 March 2024

20,250



Amortisation


At 1 April 2023
20,250



At 31 March 2024

20,250



Net book value



At 31 March 2024
-



At 31 March 2023
-



Page 8

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

5.


Tangible fixed assets





Plant & machinery
Motor vehicles
Office equipment
Total

£
£
£
£



Cost or valuation


At 1 April 2023
90,441
48,300
2,349
141,090



At 31 March 2024

90,441
48,300
2,349
141,090



Depreciation


At 1 April 2023
43,736
41,853
2,187
87,776


Charge for the year on owned assets
11,678
1,612
40
13,330



At 31 March 2024

55,414
43,465
2,227
101,106



Net book value



At 31 March 2024
35,027
4,835
122
39,984



At 31 March 2023
46,705
6,447
162
53,314


6.


Stocks

2024
2023
£
£

Finished goods and goods for resale
42,084
67,760

42,084
67,760


Page 9

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

7.


Debtors

2024
2023
£
£


Trade debtors
42,568
25,950

Other debtors
4,707
-

47,275
25,950



8.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
33,083
39,053

33,083
39,053


Page 10

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

9.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
7,472
29,306

Trade creditors
12,451
27,836

Other taxation and social security
28,691
22,619

Obligations under finance lease and hire purchase contracts
5,238
5,203

Other creditors
46,391
33,669

Accruals and deferred income
3,400
3,400

103,643
122,033


The following liabilities were secured:

2024
2023
£
£



Bank loans
5,476
5,853

5,476
5,853

Details of security provided:

The amounts included in bank loans and overdrafts above are secured by a fixed charge and a floating charge over all the property or undertaking of the company.

Page 11

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

10.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
30,209
37,614

Net obligations under finance leases and hire purchase contracts
2,183
7,421

32,392
45,035


The following liabilities were secured:

2024
2023
£
£



Bank loans
30,209
35,618

30,209
35,618

Details of security provided:

The amounts included in bank loans above are secured by a fixed charge and a floating charge over all the property or undertaking of the company.

Page 12

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

11.


Loans


Analysis of the maturity of loans is given below:


2024
2023
£
£

Amounts falling due within one year

Bank loans
7,472
29,306


7,472
29,306

Amounts falling due 1-2 years

Bank loans
5,547
7,863


5,547
7,863

Amounts falling due 2-5 years

Bank loans
17,496
16,607


17,496
16,607

Amounts falling due after more than 5 years

Bank loans
7,166
13,144

7,166
13,144

37,681
66,920



12.


Hire purchase and finance leases


Minimum lease payments under hire purchase fall due as follows:

2024
2023
£
£


Within one year
5,238
5,203

Between 1-5 years
2,183
7,421

7,421
12,624

Page 13

 
KEITH HARTE BLOODSTOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

13.


Pension commitments

The Company operates a defined contributions pension scheme. 
The assets of the scheme are held separately from those of the Company  in an independently administered fund. 
The pension cost charge represents contributions payable by the Company  to the fund and amounted to £477 (2023 - £555) . 
Contributions totalling £43 (2023 - £104) were payable to the fund at the balance sheet date and are included in creditors.

 
Page 14